A detailed history of Brinker Capital Investments, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 46,595 shares of EW stock, worth $3.51 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
46,595
Previous 42,559 9.48%
Holding current value
$3.51 Million
Previous $3.52 Million 1.17%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $275,658 - $352,907
4,036 Added 9.48%
46,595 $3.48 Million
Q3 2022

Nov 01, 2022

SELL
$82.37 - $107.29 $103,291 - $134,541
-1,254 Reduced 2.86%
42,559 $3.52 Million
Q2 2022

Jul 18, 2022

SELL
$86.5 - $128.27 $265,987 - $394,430
-3,075 Reduced 6.56%
43,813 $4.17 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $130,406 - $164,146
-1,279 Reduced 2.66%
46,888 $5.52 Million
Q4 2021

Feb 08, 2022

SELL
$106.37 - $130.68 $94,456 - $116,043
-888 Reduced 1.81%
48,167 $6.24 Million
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $103,290 - $129,064
1,232 Added 2.58%
49,055 $5.08 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $3.64 Million - $4.2 Million
-46,276 Reduced 49.18%
47,823 $4 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $3.16 Million - $4.02 Million
44,081 Added 88.13%
94,099 $8.59 Million
Q3 2020

Dec 03, 2020

BUY
$67.19 - $87.44 $3.36 Million - $4.37 Million
50,018 New
50,018 $3.99 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $31,759 - $38,921
-516 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $10,367 - $11,980
186 Added 56.36%
516 $95,000
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $15,803 - $21,136
330 New
330 $63,000
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $2,742 - $3,481
-60 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $2,547 - $3,078
60 New
60 $9,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.